dermavir
Vaccineexperimental
Clinical trial activity
3 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2005 (NCT00712530)
Timeline
Indications
Studied for
Mechanism of action
- Human immunodeficiency virus type I enhancer-binding protein 1Immunity, active
HIV immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dermavir
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00711230 | Phase 2 | Apr 1, 2008 | Genetic Immunity, University of Hamburg |
| NCT00614640 | Phase 1/Phase 2 (Phase 2) | Feb 11, 2008 | George Washington University, National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), New York University, University of Colorado |
| NCT00712530 | Phase 1 | Jan 1, 2005 | Genetic Immunity, Saint Laszlo Hospital |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genetic Immunity | For profit | 2 | 2 | 2 | 2005 |
| George Washington University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2008 |
| National Institute of Child Health and Human Development (NICHD) | Government | 1 | 0 | 1 | 2008 |
| New York University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Saint Laszlo Hospital | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of Colorado | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Hamburg | Academic/Hospital | 1 | 0 | 1 | 2008 |
8 organizations
Page 1 / 1